News from celsion corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 12, 2015, 08:00 ET

Celsion Corporation Reports Year End 2014 Financial Results and Provides Business Update

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the year ended December 31,...

Mar 05, 2015, 08:00 ET

Celsion Corporation to Hold Year-End 2014 Financial Results Conference Call on Thursday, March 12, 2015

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss year-end 2014 financial results and...

Feb 23, 2015, 08:00 ET

Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox® in Primary Liver Cancer

Celsion Corporation (NASDAQ: CLSN) today announced updated results from its retrospective analysis of the Company's 701-patient HEAT Study of...

Feb 20, 2015, 08:00 ET

Celsion Corporation Presents Clinical and Preclinical Data for GEN-1 IL-12 Immunotherapy in Ovarian Cancer at the Molecular Medicine TRI-Conference

 Celsion Corporation (NASDAQ: CLSN), a fully-integrated oncology company focused on the development of a high potential portfolio of innovative...

Jan 21, 2015, 10:07 ET

Celsion Corporation y myTomorrows se asocian para presentar el programa de acceso primario ThermoDox® en Europa

- Celsion Corporation y myTomorrows se asocian para presentar el programa de acceso primario ThermoDox® en Europa para los pacientes con...

Jan 20, 2015, 08:00 ET

Celsion Corporation and myTomorrows Partner to Introduce ThermoDox® Early Access Program in Europe for Patients with Recurrent Chest Wall Breast Cancer

Celsion Corporation (NASDAQ:CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer treatments,...

Jan 20, 2015, 08:00 ET

Celsion Corporation und myTomorrows rufen in Europa gemeinsames ThermoDox® Early Access-Programm für Patienten mit rezidivierendem Brustkrebs an der Brustwand ins Leben

Celsion Corporation (NASDAQ:CLSN), ein vollintegriertes Onkologie-Unternehmen, das sich auf die Entwicklung eines Portfolios an innovativen...

Jan 20, 2015, 08:00 ET
Jan 06, 2015, 08:00 ET

Celsion Corporation Submits DNA-based Immunotherapy Clinical Protocol to the FDA as Part of a First Line Treatment for Ovarian Cancer

Celsion Corporation (Celsion) (NASDAQ:CLSN), a fully-integrated oncology company focused on the development of a portfolio of innovative cancer...

Nov 11, 2014, 08:00 ET

Celsion Corporation Reports Third Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the third quarter ended...

Nov 05, 2014, 08:00 ET

Celsion Corporation Receives VHP Approval to Initiate OPTIMA Study in Europe

Celsion Corporation (NASDAQ: CLSN) announced today that the Phase III OPTIMA Study was approved via Europe's centralized Voluntary Harmonization...

Nov 04, 2014, 08:00 ET

Celsion Corporation to Hold Third Quarter 2014 Financial Results Conference Call on Tuesday, November 11, 2014

 Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss its third quarter 2014 financial...

Oct 29, 2014, 08:00 ET

Celsion Presents Preclinical Data for its TheraSilence™ Platform at the miRNA World Conference Workshop on miRNA Delivery

 Celsion Corporation (NASDAQ: CLSN) today announced the presentation of data related to TheraSilence™, the Company's lung-specific RNA...

Oct 07, 2014, 17:00 ET

Celsion Announces Appointment of Michael H. Tardugno to Executive Chairman of the Board of Directors

 Celsion Corporation (NASDAQ: CLSN) announced that the Board of Directors has appointed Michael H. Tardugno, the Company's President and CEO,...

Oct 07, 2014, 16:35 ET

Celsion Announces The Unexpected Passing of Max E. Link, Ph.D., Chairman of the Board

 Celsion Corporation (NASDAQ: CLSN) is saddened to announce the passing of Max E. Link, Ph.D., a Director and the Chairman of the Board of...

Sep 08, 2014, 08:00 ET

Celsion Announces Highlights from Three Presentations Given at the International Liver Cancer Association 2014 Annual Conference

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced highlights from three presentations by...

Sep 04, 2014, 09:05 ET
Sep 02, 2014, 08:00 ET

Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer

Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that the first patient has been enrolled in its pivotal...

Aug 28, 2014, 08:00 ET

Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference

 Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that Michael H. Tardugno, Celsion's President...

Aug 07, 2014, 08:00 ET

Celsion Corporation Reports Second Quarter 2014 Financial Results

 Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced financial results for the second quarter ended June...